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Background: The purpose of this study was to assess the quality of methodology in orthopaedics-related
randomized controlled trials (RCTs) published from January 2006 to December 2010 in the top orthopaedic journals
based on impact scores from the Thompson ISI citation reports (2010).
Methods: Journals included American Journal of Sports Medicine; Journal of Orthopaedic Research; Journal of Bone
and Joint Surgery, American; Spine Journal; and Osteoarthritis and Cartilage. Each RCT was assessed on ten criteria
(randomization method, allocation sequence concealment, participant blinding, outcome assessor blinding,
outcome measurement, interventionist training, withdrawals, intent to treat analyses, clustering, and baseline
characteristics) as having empirical evidence for biasing treatment effect estimates when not performed properly.
Results: A total of 232 RCTs met our inclusion criteria. The proportion of RCTs in published journals fell from 6% in
2006 to 4% in 2010. Forty-nine percent of the criteria were fulfilled across these journals, with 42% of the criteria
not being amendable to assessment due to inadequate reporting. The results of our regression revealed that a
more recent publication year was significantly associated with more fulfilled criteria (β = 0.171; CI = −0.00 to 0.342;
p = 0.051).
Conclusion: In summary, very few studies met all ten criteria. Thus, many of these studies likely have biased
estimates of treatment effects. In addition, these journals had poor reporting of important methodological aspects.Background
Randomized controlled trials (RCTs) provide strong evi-
dence for efficacy of healthcare interventions [1]. Care-
fully planned and well-executed RCTs give us the best
estimates of treatment effect and can thus guide clinical
decision making [2,3], although trials that lack methodo-
logical rigor cause over- or underestimation of treatment
effect sizes due to bias [4-6]. Hence, efforts have been
undertaken toward improving the design and reporting
of RCTs [1,6-11].
While RCTs represent a small proportion of original
research published in surgical journals [12,13], they still
represent an important component of the literature and
a high level of evidence [14]. But, this literature appears
to indicate that surgical RCTs lag behind the general
literature in terms of methodological quality. Methodo-
logical quality mainly refers to the formal aspects of* Correspondence: lchess@med.wayne.edu
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study found that only 33% of RCTs published in surgical
journals but 75% published in general medicine journals
were of high quality [15]. RCTs of orthopaedic surgery ap-
pear to be no better, with greater than half of the RCTs in
one study lacking proper concealment of randomization,
blinding of outcome assessors and reporting of reasons for
excluding patients [16]. In another study looking at the
quality of RCTs in pediatric orthopaedics, the authors
found that only 19% of the included articles met their cri-
teria for high quality [12]. In contrast, it appears that
RCTs published in general internal medicine journals is of
generally of higher quality. For example, Moher et al. in-
cluded 211 reports of RCTs from the top four English-
language internal medicine journals and found that
greater than 60% of RCTs were of high quality [17].
Therefore, it is obvious that RCTs in orthopaedic surgery
are in need of improvement.
It is important to note the difference between meth-
odological quality and reporting quality. Our study is
designed to evaluate the methodological conduct ofentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Risk of bias criteria
1. Was the randomization method to groups appropriate?
2. Was the allocation sequence concealed from those assigning
patients to groups?
3. Were the participants blind to the intervention?
4. Were the outcome assessors (for the primary outcome) blind to the
intervention?
5. Was the outcome measurement performed in the same manner
with similar intensity in the groups being compared?
6. Were similarly trained individuals administering the intervention
across groups?
7. Were all the withdrawals described?
8. Were all originally randomized participants analyzed in the groups
they were assigned to (i.e., an intention-to-treat analysis)?
9. Was clustering at the group level accounted for in the analyses?
10. Were the groups similar at baseline?
Table 2 Ratings for each methodological quality criterion
within and across journals




AJSM 70.3% 9.5% 20.3%
JBJS 74.5% 6.6% 18.9%
JOR 57.1% 0.0% 42.9%
OC 58.3% 8.3% 33.3%
SJ 56.3% 0.0% 43.8%
Mean 63.3% 4.9% 31.8%
Concealment of Subject
Allocation
AJSM 66.2% 8.1% 25.7%
JBJS 75.5% 6.6% 17.9%
JOR 57.1% 0.0% 42.9%
OC 61.1% 5.6% 33.3%
SJ 56.3% 0.0% 43.8%
Mean 63.2% 4.1% 32.7%
Blinding of Participants AJSM 14.9% 18.9% 66.2%
JBJS 20.8% 23.6% 55.7%
JOR 14.3% 0.0% 85.7%
OC 30.6% 16.7% 52.8%
SJ 25.0% 37.5% 37.5%
Mean 21.1% 19.3% 59.6%
Blinding of Outcome Assessor AJSM 51.4% 14.9% 33.8%
JBJS 45.3% 21.7% 33.0%
JOR 57.1% 0.0% 42.9%
OC 61.1% 2.8% 36.1%
SJ 37.5% 18.8% 43.8%
Mean 50.5% 11.6% 37.9%
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task difficult. While it is imperative to decipher between
reporting and methodology, it can be tempting to draw
similar conclusions from both. This will ultimately ham-
per a true risk of bias assessment and must not be car-
ried out.
To our knowledge, there has not been an assessment
of the methodological quality, or risk of bias, of RCTs
across the top journals in orthopaedics. Nor has there
been an effort to characterize the proportions of pub-
lished papers that represent the highest levels of evi-
dence. The purpose of the present study was to assess
the risk of bias of all randomized trials published in the
last 5 years of the top five journals in orthopaedics.Figure 1 Trial flow diagram.
Outcome Measurements
Performed in the Same Manner
AJSM 91.9% 1.4% 6.8%
JBJS 95.3% 0.9% 3.8%
JOR 100.0% 0.0% 0.0%
OC 97.2% 0.0% 2.8%
SJ 87.5% 0.0% 12.5%
Mean 94.4% 0.5% 5.2%
Interventions Administration by
Similarly Trained Individuals
AJSM 79.7% 1.4% 18.9%
JBJS 48.1% 1.9% 50.0%
JOR 14.3% 0.0% 85.7%
Osteo 0.0% 0.0% 100.0%
SJ 12.5% 0.0% 87.5%
Mean 30.9% 0.7% 68.4%
Description of Compliance With
the Intervention
AJSM 77.0% 21.6% 1.4%
JBJS 64.2% 35.8% 0.0%
JOR 28.6% 71.4% 0.0%
OC 83.3% 16.7% 0.0%
SJ 56.3% 43.8% 0.0%
Mean 61.9% 37.9% 0.3%
Table 2 Ratings for each methodological quality criterion
within and across journals (Continued)
Intention-To-Treat Analysis AJSM 39.2% 2.7% 58.1%
JBJS 39.6% 1.9% 58.5%
JOR 14.3% 0.0% 85.7%
Osteo 63.9% 0.0% 36.1%
SJ 50.0% 0.0% 50.0%
Mean 41.4% 0.9% 57.7%
Was Clustering Accounted for in
the Analysis?
AJSM 0.0% 0.0% 100.0%
JBJS 0.9% 0.0% 99.1%
JOR 0.0% 0.0% 100.0%
OC 0.0% 0.0% 100.0%
SJ 0.0% 0.0% 100.0%
Mean 0.2% 0.0% 99.8%
Were the Groups Similar at
Baseline?
AJSM 74.3% 4.1% 21.6%
JBJS 71.7% 6.6% 21.7%
JOR 42.9% 0.0% 57.1%
OC 63.9% 25.0% 11.1%
SJ 68.8% 6.3% 25.0%
Mean 64.3% 8.4% 27.3%
*AJSM American Journal of Sports Medicine, JBJS Journal of Bone and Joint
Surgery, JOR Journal of Orthopaedic Research, OC Osteoarthritis and Cartilage,
SJ Spine Journal.
Table 3 Sub-group analysis of item responses by
anatomical region (article n = 240)
Randomization Yes (%) No (%) Not reported (%)
Spine& Neck 14(60.9) 0(0) 9(39.1)
Upper Extremity 32(78.1) 3(7.3) 6(14.6)
Lower Extremity 112(67.9) 14(8.5) 39(23.6)
Mixed 7(70.0) 0(0) 3(30.0)
Allocation concealment
Spine& Neck 14(60.9) 0(0) 9(39.1)
Upper Extremity 32(78.1) 3 (7.3) 6(14.6)
Lower Extremity 111(67.3) 12(7.3) 42(25.5)
Mixed 7(70.0) 0(0) 3(30.0)
Blinding of Participants
Spine& Neck 6(26.1) 7(30.4) 10(43.5)
Upper Extremity 6(14.6) 8(19.5) 27(65.9)
Lower Extremity 35(21.2) 34(20.6) 96(58.2)
Mixed 2(20.0) 2(20.0) 6(60.0)
Blinding of Outcome Assessors
Spine& Neck 11(47.8) 3(13.0) 9(39.1)
Upper Extremity 18(43.9) 10(24.4) 13(31.7)
Lower Extremity 82(49.7) 24(14.6) 59(35.8)
Mixed 7(70.0) 1(10.0) 2(20.0)
Outcome Measurement
Spine& Neck 21(91.3) 0(0) 2(8.7)
Upper Extremity 39(95.1) 0(0) 2(4.9)
Lower Extremity 156(94.6) 2(1.2) 7(4.2)
Mixed 9(90.0) 0(0) 1(10.0)
Similarly Trained Individuals
Spine& Neck 5(21.7) 0(0) 18(78.3)
Upper Extremity 24(58.5) 1(2.4) 16(39.0)
Lower Extremity 81(49.1) 2(1.2) 82(49.7)
Mixed 3(30.0) 0(0) 7(70.0)
Compliance with Intervention
Spine& Neck 13(56.5) 10(43.5) 0(0)
Upper Extremity 29(70.7) 12(29.3) 0(0)
Lower Extremity 119(72.1) 45(27.3) 1(0.6)
Mixed 5(50.0) 5(50.0) 0(0)
Intent to Treat Analysis
Spine& Neck 9(39.1) 1(4.4) 13(56.5)
Upper Extremity 20(48.8) 1(2.4) 20(48.8)
Lower Extremity 70(42.4) 2(1.2) 93(56.4)
Mixed 4(40.0) 0(0) 6(60.0)
Clustering
Spine& Neck 0(0) 0(0) 23(100)
Upper Extremity 0(0) 0(0) 41(100)
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Search strategy
We determined the top five journals in orthopaedic surgery
by their impact scores from the Thompson ISI citation re-
ports. These journals included the American Journal of
Sports Medicine (AJSM), Journal of Orthopaedic Research
(JOR), Journal of Bone and Joint Surgery, American (JBJS
Am), Spine Journal (SJ) and Osteoarthritis and Cartilage
(OC). These journals were hand searched on the journal’s
website and assessed for reports for inclusion by one indi-
vidual (LC). Decisions regarding inclusion of potential stud-
ies were based on the following criteria: (1) consisted solely
of human subjects, (2) random subject allocation, (3) the
experimental design included both treatment and control
groups comparing an orthopaedic intervention, (4) and had
a publication date between January 2006 and December
2010 in the journals mentioned above. These criteria were
used as a measure of a methodological quality based
Cochrane Collaboration’s widely accepted risk of bias tool
as well as Modern Epidemiology 3rd Edition risk of bias as-
sessment recommendations. It is important to note there
was no formal protocol for this assessment.
Data extraction
The investigators separately and independently extracted
data from each study using preformatted Excel (Microsoft,
Redmond, WA) spreadsheets. Extracted data included:
Table 3 Sub-group analysis of item responses by
anatomical region (article n = 240) (Continued)
Lower Extremity 1(0.6) 0(0) 164(99.4)
Mixed 0(0) 0(0) 10(100)
Similar at Baseline
Spine& Neck 17(73.9) 1(4.4) 5(21.7)
Upper Extremity 30(73.2) 0(0) 11(26.8)
Lower Extremity 117(70.9) 16(9.7) 32(19.4)
Mixed 4(40.0) 3(30.0) 3(30.0)
Table 4 Sub-group analysis of item responses by subject
Randomization Y N DK
Adult reconstruction 33(71.7) 3(6.5) 10(21.7)
Pediatric Orthopaedic Surgery 5(71.4) 2(28.6) 0(0)
Sports Medicine 50(71.4) 6(8.6) 14(20.0)
Trauma 13(86.7) 1(6.7) 1(6.7)
Foot and Ankle 20(69.0) 2(6.9) 7(24.1)
Hand and Upper Extremity 11(84.6) 0(0) 2(15.4)
Spine 13(56.5) 0(0) 10(43.5)
OA 20(57.1) 3(8.6) 12(34.3)
Allocation Concealment
Adult reconstruction 33(71.7) 3(6.5) 10(21.7)
Pediatric Orthopaedic Surgery 5(71.4) 2(28.6) 0(0)
Sports Medicine 48(68.6) 5(7.1) 17(24.3)
Trauma 13(86.7) 1(6.7) 1(6.7)
Foot and Ankle 20(69.0) 2(6.9) 7(24.1)
Hand and Upper Extremity 11(84.6) 0(0) 2(15.4)
Spine 13(56.5) 0(0) 10(43.5)
OA 21(60.) 2(5.7) 12(34.3)
Blinding of Participants
Adult reconstruction 10(21.7) 9(19.6) 27(58.7)
Pediatric Orthopaedic Surgery 2(28.6) 4(57.1) 1(14.3)
Sports Medicine 10(14.3) 10(14.3) 50(71.4)
Trauma 3(20.0) 5(33.3) 7(46.7)
Foot and Ankle 5(17.2) 9(31.0) 15(51.7)
Hand and Upper Extremity 3(23.1) 2(15.4) 8(61.5)
Spine 5(21.7) 7(30.4) 11(47.8)
OA 11(31.4) 5(14.3) 19(54.3)
Blinding of Assessors
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All included studies were assessed on ten criteria related
to risk of bias (Table 1). The ten criteria required sufficient
reporting regarding randomization method, allocation
sequence concealment, participant blinding, outcome as-
sessor blinding, outcome measurement, interventionist
training, withdrawals, intent to treat analyses, clustering,
and baseline characteristics. For each of these criteria the
RCT was judged as fulfilling each criterion (indicated as a
“Yes”), not fulfilling it (indicated as a “No”) or having
insufficient information to determine fulfillment (“Not
Reported”) (see Figure 1). In order to be considered a
“Yes” the paper must have included a complete descrip-
tion regarding the process and outcome of each criterion.
If investigators felt that there was too little information or
that they would be unable to replicate the process based
on unclear reporting, the article was designated as a “Not
Reported” for that criterion. A complete lack of reporting
or an erroneous method (i.e., Randomization by patient
number or date of birth) was marked as “No.” Disagree-
ments were documented and resolved by discussion be-
tween data collectors along with the primary investigator.Adult reconstruction 20(43.5) 8(17.4) 18(39.1)
Pediatric Orthopaedic Surgery 3(42.9) 2(28.6) 2(28.6)
Sports Medicine 34(48.6) 10(14.3) 26(37.1)
Trauma 9(60.0) 3(20.0) 3(20.0)
Foot and Ankle 14(48.3) 6(20.7) 9(31.0)
Hand and Upper Extremity 6(46.2) 4(30.8) 3(23.1)
Spine 10(43.5) 3(13.0) 10(43.5)
OA 22(62.9) 1(2.9) 12(34.3)
Outcome Measurement
Adult reconstruction 44(95.7) 1(2.2) 1(2.2)
Pediatric Orthopaedic Surgery 7(100) 0 (0) 0 (0)
Sports Medicine 63(90.0) 1(1.4) 6(8.6)
Trauma 14(93.3) 0(0) 1(6.7)
Foot and Ankle 28(96.6) 0(0) 1(3.5)
Hand and Upper Extremity 13(100) 0(0) 0(0)
Spine 21(91.3) 0(0) 2(8.7)
OA 34(97.1) 0(0) 1(2.9)Statistical analysis
Statistical analyses included calculating the mean num-
ber of criteria that were met (“Yes), not met (“No”), or
of unknown fulfillment (“Not Reported”) within and
across all journals. First, we assessed the distribution of
Yes/No/NotReported of each article. Then we calculated
the mean proportion of fulfilled items for all the articles
from the same journals stratified by criterion (Table 2).
We then compared these mean proportions across
journals using an analysis of variance (ANOVA) to test
for differences in reporting quality. To note, the more
favorable distribution is one with a greater proportion of
fulfilled items, indicating that the journal has met more
criteria for methodological quality. Linear regression was
also applied with the outcome variable being the total
number of fulfilled items per trial and predictor variables
being journal impact factor and year of publication. We
also performed a sub-analysis on the proportion of met
Table 4 Sub-group analysis of item responses by subject
(Continued)
Similarly Trained Individuals
Adult reconstruction 25(54.4) 0(0) 21(45.7)
Pediatric Orthopaedic Surgery 3(42.9) 0(0) 4(57.1)
Sports Medicine 54(77.1) 1(1.4) 15(21.4)
Trauma 6(40.0) 1(6.7) 8(53.3)
Foot and Ankle 17(58.6) 1(3.5) 11(37.9)
Hand and Upper Extremity 4(30.8) 0(0) 9(69.2)
Spine 4(17.4) 0(0) 19(82.6)
OA 0(0) 0(0) 35(100)
Compliance with Intervention
Adult reconstruction 32(69.6) 14(30.4) 0(0)
Pediatric Orthopaedic Surgery 5(71.4) 2(28.6) 0(0)
Sports Medicine 53(75.7) 17(24.3) 0(0)
Trauma 9(60.0) 6(40.0) 0(0)
Foot and Ankle 18(62.1) 10(34.5) 1(3.5)
Hand and Upper Extremity 8(61.5) 5(38.5) 0(0)
Spine 12(52.2) 11(47.8) 0(0)
OA 29(82.9) 6(17.1) 0(0)
Intent to Treat Analysis
Adult reconstruction 14(30.4) 1(2.2) 31(67.4)
Pediatric Orthopaedic Surgery 5(71.4) 0(0) 2(28.6)
Sports Medicine 26(37.1) 2(2.9) 42(60.0)
Trauma 6(40.0) 0(0) 9(60.0)
Foot and Ankle 15(51.7) 0(0) 14(48.3)
Hand and Upper Extremity 7(52.9) 0(0) 6(46.2)
Spine 8(34.8) 1(4.4) 14(60.9)
OA 22(62.9) 0(0) 13(37.1)
Clustering
Adult reconstruction 1(2.2) 0(0) 45(97.8)
Pediatric Orthopaedic Surgery 0(0) 0(0) 7(100)
Sports Medicine 0(0) 0(0) 70(100)
Trauma 0(0) 0(0) 15(100)
Foot and Ankle 0(0) 0(0) 29(100)
Hand and Upper Extremity 0(0) 0(0) 13(100)
Spine 0(0) 0(0) 23(100)
OA 0(0) 0(0) 35(100)
Similar at Baseline
Adult reconstruction 33(71.7) 4(8.7) 9(19.6)
Pediatric Orthopaedic Surgery 6(85.7) 1(14.3) 0(0)
Sports Medicine 54(77.1) 3(4.3) 13(18.6)
Trauma 9(60.0) 2(13.3) 4(26.7)
Foot and Ankle 19(65.5) 0(0) 10(34.5)
Table 4 Sub-group analysis of item responses by subject
(Continued)
Hand and Upper Extremity 8(61.5) 0(0) 5(38.5)
Spine 17(73.9) 1(4.4) 5(21.7)
OA 22(62.9) 9(25.7) 4(11.4)
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ical region, study size and orthopedic specialty (see
Tables 3, 4, 5 and 6). All statistical tests had significance
set at p = 0.05.Results
We identified a total of 261 RCTs of which 232 met out
inclusion criteria. The most common reason for exclusion
was the lack of human participants in the RCTs (N = 29).
JBJS Am accounted for the largest number of included
RCTs (N = 106) followed by AJSM (N= 74), OC (N = 36),
SJ (N = 16) and JOR (N= 7). A total of 49% of the criteria
were fulfilled across these journals, with 42% of the criteria
not being amendable to assessment due to inadequate
reporting (Table 7). The RCTs from AJSM had the highest
number of fulfilled criteria, or were at the lowest risk of
bias, while RCTs from SJ and JBJS Am had the highest
number of unfulfilled criteria, and JOR had the largest
number of unknown fulfillment of criteria (Table 7). Less
than 1% of the included RCTs fulfilled all ten methodo-
logical criteria. Results of the ANOVA test revealed that
the difference in proportion of items fulfilled (“Yes”) be-
tween studies was statistically significant (p = 0.034) at
alpha = 0.05 level.
OC had the largest proportion of “yes” ratings, or ad-
equate fulfillment, for four of the ten criteria (proper
analysis, description of withdrawals/ compliance, subject
blinding, outcome assessor blinding), JBJS Am was the
leader for three criteria (randomization process, alloca-
tion concealment, accounting for clustering), AJSM led
for two criteria (baseline characteristics, intervention ad-
ministration) and JOR led in one category (blinded out-
come assessment). Table 2 contains the complete list of
all methodological quality criteria ratings within and
across journals.
We also found that the total number of RCTs pub-
lished increased slightly from 54 in 2006 to 61 in 2008
but fell to 57 and 46 in 2009 and 2010, respectively. But,
the proportion of RCTs per total published articles fell
from 6% in 2006 to 4% in 2010. The results of our re-
gression revealed that the year of publication was signifi-
cantly associated with more fulfilled criteria (β = 0.171;
CI = −0.00 to 0.342; p = 0.051), but the impact factor was
not a significant predictor (β = 0.307; CI = −0.221 to
0.836; p = 0.253). Figure 2 contains the ratings across all
criteria by year of publication.
Table 5 Sub-group analysis of item responses by
Geographic Location
Randomization Y N DK
Asia 11(64.7) 4(23.5) 2(11.8)
Europe 78(75.0) 6(5.8) 20(19.2)
N. America 66(62.9) 7(6.7) 32(30.5)
Oceana 9(81.8) 0(0) 2(18.2)
Mixed 1(50.0) 0(0) 1(50.0)
Allocation Concealment
Asia 11(64.7) 4(23.5) 2(11.8)
Europe 78(75.0) 4(3.9) 22(21.2)
N. America 66(62.9) 7(6.7) 32(30.5)
Oceana 8(72.7) 0(0) 3(27.3)
Mixed 1(50.0) 0(0) 1(50.0)
Blinding of Participants
Asia 2(11.8) 0(0) 15(88.2)
Europe 21(20.2) 24(23.1) 59(56.7)
N. America 23(21.9) 24(22.9) 58(55.2)
Oceana 2(18.2) 3(27.3) 6(54.6)
Mixed 1(50.0) 0(0) 1(50.0)
Blinding of Assessors
Asia 9(52.9) 2(11.8) 6(35.3)
Europe 51(49.0) 22(21.2) 31(29.8)
N. America 51(48.6) 13(12.4) 41(39.1)
Oceana 6(54.6) 1(9.1) 4(36.4)
Mixed 1(50.0) 0(0) 1(50.0)
Outcome Measurement
Asia 15(88.2) 1(5.9) 1(5.9)
Europe 99(95.2) 0(0) 5(4.8)
N. America 99(94.3) 1(1.0) 5(4.8)
Oceana 10(90.0) 0(0) 1(9.1)
Mixed 2(100) 0(0) 0(0)
Similarly Trained Individuals
Asia 10(58.8) 0(0) 7(41.2)
Europe 54(51.9) 1(1.0) 49(47.1)
N. America 46(43.8) 2(1.9) 57(54.3)
Oceana 3(27.3) 0(0) 8(72.7)
Mixed 0(0) 0(0) 2(100)
Compliance with Intervention
Asia 11(64.7) 5(29.4) 1(5.9)
Europe 76(73.1) 28(26.9) 0(0)
N. America 69(65.7) 36(34.3) 0(0)
Oceana 9(81.8) 2(18.2) 0(0)
Mixed 1(50.0) 1(50.0) 0(0)
Table 5 Sub-group analysis of item responses by
Geographic Location (Continued)
Intent to Treat Analysis
Asia 6(6.1) 0(0) 11(64.7)
Europe 47(45.2) 1(1.0) 56(53.9)
N. America 43(41.0) 3(2.9) 59(56.2)
Oceana 5(45.5) 0(0) 6(54.6)
Mixed 2(100) 0(0) 0(0)
Clustering
Asia 0(0) 0(0) 17(100)
Europe 0(0) 0(0) 104(100)
N. America 1(1.0) 0(0) 104(99.1)
Oceana 0(0) 0(0) 11(100)
Mixed 0(0) 0(0) 2(100)
Similar at Baseline
Asia 13(76.5) 1(5.9) 3(17.7)
Europe 67(64.4) 8(7.7) 29(27.9)
N. America 79(75.2) 9(8.6) 17(16.2)
Oceana 7(63.6) 2(18.2) 2(18.2)
Mixed 2(100) 0(0) 0(0)
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We found that only a very small proportion of the ana-
lyzed RCTs met all ten methodological quality criteria,
indicating that many of these studies are at a serious risk
of bias, but that these trials are improving with time
(Figure 2). In addition, we found that many RCTs did
not report sufficient information to judge if they met
many of the included criteria. Overall, it is clear that the
methodological and reporting quality in orthopaedic
RCTs has significant room for improvement.
The poor methodological quality of orthopaedic RCTs
has been shown in previous literature [12]. Dulai et al. [12]
reported that despite increasing numbers of RCTs, only
19% of pediatric orthopaedic trials evaluated met the
standard for methodological acceptability. They found that
in particular there was inadequate rigor and reporting of
randomization methods, use of inappropriate or poorly de-
scribed outcome measures, inadequate description of in-
clusion and exclusion criteria, and inappropriate statistical
analysis. In another study, Bhandari and colleagues [13]
assessed 72 RCTs from JBJS Am published from January
1988 to the end of 2000 and found that while the number
of RCTs increased over the years, their mean overall score
was only 68.1% of the total Detsky quality score. Similar to
our study, they found that more than half of the RCTs were
limited by lack of concealed allocation, lack of blinding of
outcome assessors, and failure to report reasons for ex-
cluding patients [14]. Furthermore, Herman and colleagues
[14] found that only 35% of the RCTs in eight leading
Table 6 Sub-group analysis of item responses by Study
Size (in quartiles)
Randomization Y N DK
Size < 51 35(61.4) 5(8.8) 17(29.8)
51 ≤ size < 81 41(70.7) 5(8.6) 12(20.7)
81 ≤ size < 158 53(84.1) 3(4.8) 7(11.1)
Size≥ 158 36(59.0) 4(6.6) 21(34.4)
Allocation Concealment
Size < 51 33(57.9) 4(7.0) 20(35.1)
51 ≤ size < 81 42(72.4) 5(8.6) 11(19.0)
81 ≤ size < 158 52(82.5) 3(4.8) 8(12.7)
Size≥ 158 37(60.7) 3(4.9) 21(34.4)
Blinding of Participants
Size < 51 9(15.8) 10(17.5) 38(66.7)
51 ≤ size < 81 9(15.5) 10(17.2) 39(67.2)
81 ≤ size < 158 15(23.8) 19(30.2) 29(46.0)
Size≥ 158 16(26.2) 12(19.7) 32(54.1)
Blinding of Assessors
Size < 51 25(43.9) 7(12.3) 25(43.9)
51 ≤ size < 81 30(51.7) 10(17.2) 18(31.0)
81 ≤ size < 158 34(54.0) 9(14.3) 20(31.8)
Size≥ 158 29(47.5) 12(19.7) 20(32.8)
Outcome Measurement
Size < 51 54(94.7) 1(1.8) 2(3.5)
51 ≤ size < 81 54(93.1) 1(1.7) 3(5.2)
81 ≤ size < 158 61(96.8) 0(0) 2(3.2)
Size≥ 158 56(91.8) 0(0) 5(8.2)
Similarly Trained Individuals
Size < 51 29(50.9) 1(1.8) 27(47.4)
51 ≤ size < 81 38(65.5) 0(0) 20(34.5)
81 ≤ size < 158 31(49.2) 2(3.2) 30(47.6)
Size≥ 158 15(24.6) 0(0) 46(75.4)
Compliance with Intervention
Size < 51 28(49.1) 29(5.9) 0(0)
51 ≤ size < 81 39(67.2) 18(31.0) 1(1.7)
81 ≤ size < 158 53(84.1) 10(15.9) 0(0)
Size≥ 158 46(75.4) 15(24.6) 0(0)
Intent to Treat Analysis
Size < 51 10(17.5) 0(0) 47(82.5)
51 ≤ size < 81 15(25.9) 0(0) 43(74.1)
81 ≤ size < 158 39(61.9) 1(1.6) 23(36.5)
Size≥ 158 39(63.9) 3(4.9) 19(31.1)
Clustering
Size < 51 0(0) 0(0) 57(100)
51 ≤ size < 81 0(0) 0(0) 58(100)
Table 6 Sub-group analysis of item responses by Study
Size (in quartiles) (Continued)
81 ≤ size < 158 1(1.6) 0(0) 62(98.4)
Size≥ 158 0(0) 0(0) 61(100)
Similar at Baseline
Size < 51 37(64.9) 2(3.5) 18(31.6)
51 ≤ size < 81 39(67.2) 3(5.2) 16(27.6)
81 ≤ size < 158 47(74.6) 7(11.1) 9(14.3)
Size≥ 158 45(73.8) 8(13.1) 8(13.1)
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which was similar to our finding of 41%. Also, Karanicolas
and colleagues [15] found that less than 10% of 171 in-
cluded orthopaedic trauma RCTs had blinded outcome as-
sessors. This is much lower than our nearly 51% finding,
the difference of which is most likely due to the broader
nature of the trials that we included, going beyond trauma
and including any orthopaedic RCTs from a select list of
orthopaedic journals.
Beyond methodological deficits in these trials some
evidence suggests, similar to our findings, that RCTs in
orthopaedic surgery fail to report much important infor-
mation [16,18]. That is, to adequately assess the quality
of any methodological component of an RCT, sufficient
information must be present in the published report to
make that assessment, and it appears many orthopaedic
RCTs fall short in this regard. For example, the most re-
cent of these investigations of reporting quality [19] ap-
plied the Consolidated Standards of Reporting Trials
(CONSORT) statement [20] to a sample of RCTs, the
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement [21] to a sample of
case–control, cohort and cross-sectional studies, and a
statistical questionnaire was used to assess all included
studies. They found that for the 100 included studies
only 58% of the CONSORT items were met on average
across the seven included journals. We found inadequate
reporting on average for approximately 42% of the itemsTable 7 Summary of overall methodological ratings by
journal
Journal title* Impact factor Yes† No Not reported
AJSM (N = 74) 3.80 0.565 0.082 0.353
JBJS (N = 106) 2.97 0.536 0.106 0.358
JOR (N = 7) 2.97 0.386 0.071 0.543
OC (N = 36) 3.95 0.519 0.075 0.406
SJ (N = 16) 3.02 0.450 0.106 0.444
Mean 0.491 0.088 0.421
*AJSM American Journal of Sports Medicine, JBJS Journal of Bone and Joint
Surgery, JOR Journal of Orthopaedic Research, OC Osteoarthritis and Cartilage,
SJ Spine Journal.
† ANOVA P = .034.
Figure 2 Percentage of RCTs Meeting Criteria by Publication Year.
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in findings between these studies can likely be accounted
for by the use of different checklist items and the inclu-
sion of different selections of journals. Either way, re-
search in the area indicates serious inadequacies in
reporting in orthopaedic RCTs. This trend of poor
reporting has been seen in other fields as well, including
internal medicine [17] and general surgery [22].
Despite the deficits, the RCTs we included did have
some common strengths. In general, the intervention
and primary outcome was well described in most papers.
Also, the proportion of methodological quality items ful-
filled increased with increasing publication year, which is
consistent with trends in internal medicine journals [17].
This is promising and may suggest that clinical trialists,
editors and reviewers are putting more emphasis on
proper methodology.
Our study has several strengths. First, we conducted a
comprehensive hand search of the tables of contents of
the top orthopaedic journals in a recent span of 5 years.
Thus, the findings presented here for the included RCTs
likely represent the most read and cited RCTs in the
orthopaedic community and therefore give an excellent
idea of the quality of the RCTs that might be impacting
clinical decision making. If in fact this assumption is
true, the trials that are the most influential are at a high
risk of having biased estimates of treatment effect. But,
due to the limited selection of journals included, it is
possible that higher quality and more influential RCTs
are being published in other journals. For example, we
found that RCTs make up only a very small proportion
of all articles published in these five journals and there-
fore may not be influencing decision making to any high
degree. In order to ensure a proper meta-analysis, our
paper is in accordance with the PRISMA Statement and
meets all criteria. Additionally, we included methodologicalquality criteria that have been empirically proven to bias
estimates of treatment effect when not properly
implemented [3,4,23-34]. All included criteria have empir-
ical evidence that not using them in RCTs or not assessing
them in systematic reviews results in bias in the estimates
of treatment effect or in misclassification of trials as high
or low quality. But, due to the lack of reporting of the in-
cluded studies we could not directly test the influence of
specific inadequacies in methodology on effect estimates.
Therefore, we cannot be certain that the flaws in method-
ology in these orthopaedic studies absolutely bias the es-
timates of treatment effect. We can only extrapolate for
the extensive literature that has shown this to be true
for RCTs in other clinical areas [3,4,23-34].
It is important to note that just because a study did not
report a certain methodology does not imply that it was
not performed. For example, in this study, subject alloca-
tion and cluster analysis had two of the lowest fulfillment
proportions. We acknowledge that descriptive reporting of
these topics may not have been emphasized despite proper
methodology and that poor reporting may not necessarily
be a proxy for poor methodology [35]. Thus, this paper
fails to account for these underreporting deficiencies and
may falsely underestimate the quality of methodology in
this literature. In any case, to adequately assess the quality
of a reported study the relevant information must be
present for the reader to assess the potential risk of bias in
the estimates of effect to determine the potential import
or not of the RCT to clinical decision-making.
In common with other authors, we can make some
recommendations on how to improve this literature.
First, we suggest that investigators include on their
team an epidemiologist, clinical epidemiologist, clinical
trial methodologist or someone with experience in
conducting RCTs and a statistician or biostatistician to
ensure proper planning and implementation of the trial.
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investigative team improves the quality of the resultant
RCT [13]. In addition, we would suggest that investiga-
tors and authors refer to the revised CONSORT state-
ment [20] and the related explanatory paper [36] to
guide them on the important information to include
when reporting their RCT. The CONSORT statement
has been shown to improve the quality of reporting in
these studies [37]. In addition to these documents, there
are other reporting guidance documents located on the
equator network website that may be of use [11]. Fi-
nally, we suggest that journal editors enforce the use of
the CONSORT statement so that published reports are
completely reported and have the best chance of being
interpreted properly for clinical decision making.Conclusions
There are some obvious flaws in the methodology and
reporting of RCTs in the orthopaedic literature. These
flaws may cause seriously biased estimates of effect in
those studies. We expect that these types of initiatives
mentioned above will improve these important types of
clinical research which are an integral aspect to improv-
ing the empirical base for orthopaedic procedures [38].
And remember, just because a study is rated as level I
evidence does not imply that it is without methodo-
logical flaws and that these flaws can bias the reported
effect estimates [39].
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